Skip to Content


Filter by:



Second Opinion

Learn about policy issues important to medical schools and teaching hospitals, with Executive Vice President Atul Grover, M.D., Ph.D.

Washington Highlights

Senate Confirms FDA Commissioner Nominee

February 26, 2016—The Senate Feb. 24 approved (89-4) the nomination of Robert Califf, M.D., to lead the Food and Drug Administration (FDA).

Prior to the floor vote, Senator Lindsey Graham (R-S.C.) urged the Senate to support Califf’s nomination adding that the “broad bipartisan support for Dr. Califf is a testament to his strong, transparent leadership and record of advancing medical breakthroughs.”

Margaret Hamburg, M.D., stepped down as FDA commissioner in March 2015. Stephen Ostroff, M.D., has since served as acting commissioner.

Last September, AAMC President and CEO Darrell G. Kirch, M.D., applauded the nomination, calling Califf “a prominent champion for medical research.” He added, “A physician scientist of Dr. Califf’s abilities and experience with clinical trials and translational research will be invaluable to advancing the science that underpins the FDA’s public health and safety mission.”

Contact:

Tannaz

.

envelope on a green background

Subscribe to Washington Highlights

RSS icon

Subscribe to RSS

Washington Highlights, a weekly electronic newsletter, features brief updates on the latest legislative and regulatory activities affecting medical schools and teaching hospitals.


Past Issues


For More Information

Jason Kleinman
Sr. Legislative Analyst, Govt. Relations
Telephone: 202-903-0806
Email: jkleinman@aamc.org